Efficacy and safety of recombinant human granulocyte colony-stimulating factor in patients with unexplained recurrent pregnancy loss: a protocol for a multicenter, randomized, double-blind, controlled trial

Unexplained recurrent pregnancy loss (uRPL), defined as the loss of two or more pregnancies without an identified cause, affects approximately 1-2% of women trying to conceive. Emerging evidence suggests that an imbalance in maternal-fetal immunological tolerance may play a key role in its pathogene...

Full description

Saved in:
Bibliographic Details
Published inCurrent controlled trials in cardiovascular medicine Vol. 26; no. 1; pp. 245 - 13
Main Authors Mu, Fangxiang, Cai, Zhuhua, Du, Lirong, Zeng, Xianghui, Zhou, Qi, Chen, Yaolong, Wang, Fang
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 14.07.2025
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…